The Survivor
I published the following essay in the 2010 “Rhetoric at Work” issue of Harlot of the Arts, a (now defunct, as far as I can tell) online literary journal started by graduate students in the Rhetoric Program at The Ohio State University Department of English, under the title “The Misplaced Rhetoric of Medicine.” Reading it again now 15 years later, I’m struck by how much of it still resonates. The Pink Ribbon crusades seem to be a thing of the past, and there are certainly other divides at play in my relationship with the patient that I am more sensitive to in 2025, but replace the word “rhetoric” with “narrative” and it’s what I still see every day in my work. If we can’t effectively listen to and act upon the stories our patients use to create their health experience, the most advanced treatments in the world won’t make a difference.
= = = = = = = = = = = = = = = = = = = =
Early in my career, I saw a 64-year-old African American woman as a new patient. I reviewed her past medical history, which was significant for a litany of serious medical conditions: diabetes, hypertension, heart disease and stroke among others. Before moving on to my examination, I asked her if she had any other medical conditions.
She replied, “I’m a survivor.”
She said the word like an incantation, an invitation to some shared and profound understanding. But I didn’t hear her and without a second thought, made a horrible mistake.
“A survivor of what?” I asked.
The confusion and contempt with which she replied, “Breast cancer” startled me. I suddenly knew, without exactly understanding why, that our relationship was over before it had even begun.
On the surface, it seemed a fair question. After all, from a medical standpoint she had survived many threats to her health. But from a rhetorical standpoint, her breast cancer was everything to her – it was her – and I was completely oblivious to that fact.
Even conditions necessitating a hysterectomy don’t strike at the core of womanhood – sexual identity, maternity – as ruthlessly and visibly as breast cancer. The intimacy of its betrayal has led to a very profound sense of pride among its victims, a pride framed by a fierce rhetoric that has come to be epitomized by one word - Survivor.
While this has obviously led to many positive outcomes – breast cancer research and treatment is light years ahead of many other forms of cancer – it has also led to a unique relationship. For the first time in history, an illness has come to define a “lifestyle.” Breast cancer survivors and their supporters are overwhelmingly proud, strong, active, committed, and engaged fighters (in the best sense of the word).
Companies picked up on this and suddenly began racing to associate their products with the “fight” against breast cancer and the extremely powerful associations that people – people with a clearly identifiable set of consumer preferences and tantalizing pool of discretionary income – made with the disease. There has never been an illness with such corporate synergy. The pink ribbon had become the new golden arches.
One can argue whether or not it’s a good thing that we live in a society in which purchasing a certain brand of kitchen mixer or golf club has been turned into a personal statement about whether or not we support people with a specific illness. But it’s hard to argue that this artificial, meticulously manufactured rhetoric doesn’t extend beyond the walls of the mall to inflict a very real, and not necessarily positive, impact on our health.
“There has never been an illness with such corporate synergy. The pink ribbon had become the new golden arches.”